Applied DNA Sciences enters manufacturing agreement with Alphazyme

Applied DNA Sciences and Alphazyme have entered into an agreement under which Alphazyme will scale-up manufacturing of Applied DNA’s proprietary Linea RNA polymerase. Under the terms of the agreement, Alphazyme will perform manufacturing process development, enabling the scaling of Linea RNAP manufacturing from its current research scale to the commercial scale necessary to empower the Company’s growing demand for the Company’s Linea IVT platform. The Linea IVT platform combines the Company’s enzymatically produced Linea DNA IVT templates and its proprietary Linea RNAP to empower the manufacture of better mRNA faster. It enables higher target mRNA yields with reduced double-stranded RNA contamination and simplified mRNA production workflows.